Sieper J - Search Results

1

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. van der Heijde D, et al. Among authors: sieper j. Arthritis Rheum. 2005 Feb;52(2):582-91. doi: 10.1002/art.20852. Arthritis Rheum. 2005. PMID: 15692973 Clinical Trial.

2

Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al.

Braun J, Sieper J, Riemekasten G, Hiepe F. Braun J, et al. Among authors: sieper j. Arthritis Rheum. 1999 Jan;42(1):196-8. doi: 10.1002/1529-0131(199901)42:1<196::AID-ANR32>3.0.CO;2-X. Arthritis Rheum. 1999. PMID: 9920036 No abstract available.

3

No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.

Sieper J, Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J. Sieper J, et al. Arthritis Rheum. 1999 Jul;42(7):1386-96. doi: 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E. Arthritis Rheum. 1999. PMID: 10403266 Clinical Trial.

4

New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.

Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E. Braun J, et al. Among authors: sieper j. Curr Opin Rheumatol. 2001 Jul;13(4):245-9. doi: 10.1097/00002281-200107000-00001. Curr Opin Rheumatol. 2001. PMID: 11555723 Review.

5

Infliximab treatment of severe ankylosing spondylitis: one-year followup.

Brandt J, Haibel H, Sieper J, Reddig J, Braun J. Brandt J, et al. Among authors: sieper j. Arthritis Rheum. 2001 Dec;44(12):2936-7. doi: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m. Arthritis Rheum. 2001. PMID: 11762956 No abstract available.

6

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Brandt J, et al. Among authors: sieper j. J Rheumatol. 2002 Jan;29(1):118-22. J Rheumatol. 2002. PMID: 11824947 Clinical Trial.

7

New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Sieper J, Braun J. Sieper J, et al. Ann Rheum Dis. 2001 Nov;60 Suppl 3(Suppl 3):iii58-61. doi: 10.1136/ard.60.90003.iii58. Ann Rheum Dis. 2001. PMID: 11890656 Free PMC article. Review.

8

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.

Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sörensen H, Zeidler H, Thriene W, Sieper J. Braun J, et al. Among authors: sieper j. Lancet. 2002 Apr 6;359(9313):1187-93. doi: 10.1016/s0140-6736(02)08215-6. Lancet. 2002. PMID: 11955536 Clinical Trial.

9

[New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].

Braun J, Sieper J. Braun J, et al. Among authors: sieper j. Z Rheumatol. 2002 Apr;61(2):151-8. doi: 10.1007/s003930200023. Z Rheumatol. 2002. PMID: 12056292 Review. German. No abstract available.

10

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Braun J, Sieper J. Braun J, et al. Among authors: sieper j. Arthritis Res. 2002;4(5):307-21. doi: 10.1186/ar592. Epub 2002 Aug 6. Arthritis Res. 2002. PMID: 12223105 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results